Please enable JavaScript to continue using this application.

Compare $EQ vs $PTHS | Chartloom

Compare

$EQ vs $PTHS

Equillium Inc · Pelthos Therapeutics Inc

Equillium Inc

PTHS

Pelthos Therapeutics Inc

Compare $EQ vs $PTHS

Comparing Equillium Inc and Pelthos Therapeutics Inc

EQEquillium Inc

PTHSPelthos Therapeutics Inc

EQEquillium Inc

Market cap

$89M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-7.8%

52W performance

-4.1%

FCF yield

-22.5%

PTHSPelthos Therapeutics Inc

Market cap

$71M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.83x

Rev growth (TTM)

—

YTD performance

-30.4%

52W performance

-27.4%

FCF yield

-70.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PTHS

Detailed metrics comparison

Equillium Inc

PTHS

Pelthos Therapeutics Inc

Market Cap

EQ$89M

PTHS$71M

Enterprise Value

EQ$32M

PTHS$71M

Price

EQ$1.41

PTHS$20.50

P/E Ratio

EQN/A

PTHSN/A

P/S Ratio

EQ2.18x

PTHS1.65x

EV/Sales

EQ0.78x

PTHS1.65x

EV/EBITDA

EQ0.00x

PTHS0.00x

P/B Ratio

EQ1.60x

PTHS2.03x

P/FCF Ratio

EQN/A

PTHSN/A

EV/FCF

EQ-1.59x

PTHS-1.41x

PEG Ratio

EQN/A

PTHSN/A

Forward P/E (NTM)

EQN/A

PTHSN/A

Forward P/S (NTM)

EQN/A

PTHS0.83x

Revenue (TTM)

EQ$0

PTHS$43M

Revenue Growth (YoY)

EQN/A

PTHSN/A

Forward Rev Growth

EQ0.0%

PTHS76.2%

Gross Margin (TTM)

EQ0.0%

PTHS78.6%

Operating Margin (TTM)

EQ0.0%

PTHS0.0%

EBITDA Margin (TTM)

EQ0.0%

PTHS-121.6%

Net Margin (TTM)

EQ0.0%

PTHS-165.2%

FCF Margin (TTM)

EQN/A

PTHS-116.6%

Net Income (TTM)

EQ$-18M

PTHS$-72M

FCF (TTM)

EQ$-20M

PTHS$-50M

EPS (TTM)

EQ-$0.15

PTHS-$20.22

ROE (TTM)

EQ-6143.0%

PTHS-7804.0%

ROA (TTM)

EQ-5372.0%

PTHS-6701.0%

ROIC (TTM)

EQ-6143.0%

PTHS-5896.0%

Cash

EQ$57M

PTHS$0

Debt

EQ$0

PTHS$0

Net Cash/Debt

EQ$57M

PTHS$0

Current Ratio (TTM)

EQ23.40x

PTHS2.05x

Quick Ratio (TTM)

EQ23.07x

PTHS1.10x

Debt/Equity (TTM)

EQ0.00x

PTHS0.81x

Debt/Assets (TTM)

EQ0.0%

PTHS0.0%

Interest Coverage (TTM)

EQN/A

PTHSN/A

Net Debt/EBITDA (TTM)

EQ0.00x

PTHS0.00x

Beta

EQ2.07

PTHS3.13

52W Performance

EQ-4.1%

PTHS-27.4%

YTD Performance

EQ-7.8%

PTHS-30.4%

% from 52W High

EQ-60.2%

PTHS-45.3%

% from 52W Low

EQ85.5%

PTHS12.7%

Asset Turnover (TTM)

EQ1.12x

PTHS0.00x

FCF Yield (TTM)

EQ-22.5%

PTHS-70.8%

Earnings Yield (TTM)

EQ-20.2%

PTHS-100.3%

Dividend Yield (TTM)

EQN/A

PTHSN/A

Rule of 40

EQ0.0

PTHS-116.6

EV/GP/RG

EQN/A

PTHS0.02

Ticker research

View EQ research View PTHS research

Metric	EQ Equillium Inc	PTHS Pelthos Therapeutics Inc
Market & Valuation
Market Cap	$89M	$71M
Enterprise Value	$32M	$71M
Price	$1.41	$20.50
P/E Ratio	N/A	N/A
P/S Ratio	2.18x	1.65x
EV/Sales	0.78x	1.65x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.60x	2.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.59x	-1.41x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.83x
Revenue & Growth
Revenue (TTM)	$0	$43M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	76.2%
Profitability
Gross Margin (TTM)	0.0%	78.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-121.6%
Net Margin (TTM)	0.0%	-165.2%
FCF Margin (TTM)	N/A	-116.6%
Net Income (TTM)	$-18M	$-72M
FCF (TTM)	$-20M	$-50M
EPS (TTM)	-$0.15	-$20.22
ROE (TTM)	-6143.0%	-7804.0%
ROA (TTM)	-5372.0%	-6701.0%
ROIC (TTM)	-6143.0%	-5896.0%
Financial Health
Cash	$57M	$0
Debt	$0	$0
Net Cash/Debt	$57M	$0
Current Ratio (TTM)	23.40x	2.05x
Quick Ratio (TTM)	23.07x	1.10x
Debt/Equity (TTM)	0.00x	0.81x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.07	3.13
52W Performance	-4.1%	-27.4%
YTD Performance	-7.8%	-30.4%
% from 52W High	-60.2%	-45.3%
% from 52W Low	85.5%	12.7%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	0.00x
FCF Yield (TTM)	-22.5%	-70.8%
Earnings Yield (TTM)	-20.2%	-100.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-116.6
EV/GP/RG	N/A	0.02
Ticker research	View EQ research	View PTHS research

Valuation

P/S Ratio

PTHS

1.65x

2.18x

EV/FCF

-1.59x

PTHS

-1.41x

Growth & revenue

Forward Revenue Growth

PTHS

76.2%

0.0%

Profitability & performance

Gross Margin

PTHS

78.6%

0.0%

ROE

-6143.0%

PTHS

-7804.0%

FCF Yield %

-22.5%

PTHS

-70.8%

52-Week Performance

-4.1%

PTHS

-27.4%

Detailed metrics comparison

Equillium Inc

PTHS

Pelthos Therapeutics Inc

Market Cap

EQ$89M

PTHS$71M

Enterprise Value

EQ$32M

PTHS$71M

Price

EQ$1.41

PTHS$20.50

P/E Ratio

EQN/A

PTHSN/A

P/S Ratio

EQ2.18x

PTHS1.65x

EV/Sales

EQ0.78x

PTHS1.65x

EV/EBITDA

EQ0.00x

PTHS0.00x

P/B Ratio

EQ1.60x

PTHS2.03x

P/FCF Ratio

EQN/A

PTHSN/A

EV/FCF

EQ-1.59x

PTHS-1.41x

PEG Ratio

EQN/A

PTHSN/A

Forward P/E (NTM)

EQN/A

PTHSN/A

Forward P/S (NTM)

EQN/A

PTHS0.83x

Revenue (TTM)

EQ$0

PTHS$43M

Revenue Growth (YoY)

EQN/A

PTHSN/A

Forward Rev Growth

EQ0.0%

PTHS76.2%

Gross Margin (TTM)

EQ0.0%

PTHS78.6%

Operating Margin (TTM)

EQ0.0%

PTHS0.0%

EBITDA Margin (TTM)

EQ0.0%

PTHS-121.6%

Net Margin (TTM)

EQ0.0%

PTHS-165.2%

FCF Margin (TTM)

EQN/A

PTHS-116.6%

Net Income (TTM)

EQ$-18M

PTHS$-72M

FCF (TTM)

EQ$-20M

PTHS$-50M

EPS (TTM)

EQ-$0.15

PTHS-$20.22

ROE (TTM)

EQ-6143.0%

PTHS-7804.0%

ROA (TTM)

EQ-5372.0%

PTHS-6701.0%

ROIC (TTM)

EQ-6143.0%

PTHS-5896.0%

Cash

EQ$57M

PTHS$0

Debt

EQ$0

PTHS$0

Net Cash/Debt

EQ$57M

PTHS$0

Current Ratio (TTM)

EQ23.40x

PTHS2.05x

Quick Ratio (TTM)

EQ23.07x

PTHS1.10x

Debt/Equity (TTM)

EQ0.00x

PTHS0.81x

Debt/Assets (TTM)

EQ0.0%

PTHS0.0%

Interest Coverage (TTM)

EQN/A

PTHSN/A

Net Debt/EBITDA (TTM)

EQ0.00x

PTHS0.00x

Beta

EQ2.07

PTHS3.13

52W Performance

EQ-4.1%

PTHS-27.4%

YTD Performance

EQ-7.8%

PTHS-30.4%

% from 52W High

EQ-60.2%

PTHS-45.3%

% from 52W Low

EQ85.5%

PTHS12.7%

Asset Turnover (TTM)

EQ1.12x

PTHS0.00x

FCF Yield (TTM)

EQ-22.5%

PTHS-70.8%

Earnings Yield (TTM)

EQ-20.2%

PTHS-100.3%

Dividend Yield (TTM)

EQN/A

PTHSN/A

Rule of 40

EQ0.0

PTHS-116.6

EV/GP/RG

EQN/A

PTHS0.02

Ticker research

View EQ research View PTHS research

Metric	EQ Equillium Inc	PTHS Pelthos Therapeutics Inc
Market & Valuation
Market Cap	$89M	$71M
Enterprise Value	$32M	$71M
Price	$1.41	$20.50
P/E Ratio	N/A	N/A
P/S Ratio	2.18x	1.65x
EV/Sales	0.78x	1.65x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.60x	2.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.59x	-1.41x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.83x
Revenue & Growth
Revenue (TTM)	$0	$43M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	76.2%
Profitability
Gross Margin (TTM)	0.0%	78.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-121.6%
Net Margin (TTM)	0.0%	-165.2%
FCF Margin (TTM)	N/A	-116.6%
Net Income (TTM)	$-18M	$-72M
FCF (TTM)	$-20M	$-50M
EPS (TTM)	-$0.15	-$20.22
ROE (TTM)	-6143.0%	-7804.0%
ROA (TTM)	-5372.0%	-6701.0%
ROIC (TTM)	-6143.0%	-5896.0%
Financial Health
Cash	$57M	$0
Debt	$0	$0
Net Cash/Debt	$57M	$0
Current Ratio (TTM)	23.40x	2.05x
Quick Ratio (TTM)	23.07x	1.10x
Debt/Equity (TTM)	0.00x	0.81x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.07	3.13
52W Performance	-4.1%	-27.4%
YTD Performance	-7.8%	-30.4%
% from 52W High	-60.2%	-45.3%
% from 52W Low	85.5%	12.7%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	0.00x
FCF Yield (TTM)	-22.5%	-70.8%
Earnings Yield (TTM)	-20.2%	-100.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-116.6
EV/GP/RG	N/A	0.02
Ticker research	View EQ research	View PTHS research